Northeast Tiger Pharmaceutical Co. Ltd. provided earnings guidance for the year ended December 31, 2014. For the period, the company may record a significant decrease in net profit and will record loss as compared to that of the corresponding period in 2013.
1st Jan change | Capi. | |
---|---|---|
+37.77% | 610.22Cr | |
-28.83% | 387.14Cr | |
+3.24% | 327.82Cr | |
-22.21% | 278.64Cr | |
-9.76% | 231.65Cr | |
+45.53% | 198.08Cr | |
+45.97% | 153.54Cr | |
-18.49% | 151.35Cr | |
-10.89% | 147.85Cr |